Lawmakers want physicians to educate prostate Ca patients about treatment options

October 28, 2004

The U.S. Senate approved a resolution encouraging physicians to inform prostate cancer patients of every treatment option available, including brachytherapy, hormonal treatments, external beam radiation, chemotherapy, surgery, and watchful waiting.

The U.S. Senate approved a resolution encouraging physicians to inform prostate cancer patients of every treatment option available, including brachytherapy, hormonal treatments, external beam radiation, chemotherapy, surgery, and watchful waiting.

The resolution states, "The Federal Government and the States should ensure that health care providers supply prostate cancer patients with appropriate information and any other tools necessary for prostate cancer patients to receive readily understandable descriptions of the advantages, disadvantages, benefits, and risks of all medically efficacious treatments."

Sen. Ben Nighthorse Campbell (R-CO) introduced and sponsored the resolution, which has 27 co-sponsors in the Senate.

"The resolution represents a milestone in educating the public about the full range of proven treatment options available to prostate cancer patients," said Sen. Campbell. "I'm proud to join in the effort to educate the public about the disease."